# Geode Capital Management LLC

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/geode-capital-management-llc-company
Canonical HTML page: https://getyourbrief.com/entity/geode-capital-management-llc-company

## Timeline

- **2026-08-16**: 13F disclosures reported — Multiple outlets reported the SEC Form 13F filings, including that Zoetis shares opened at $73.64 on Friday.
- **2026-06-30**: Q2 2026 United Super reductions — United Super cut Nebius by 20.5%, selling 3,390 shares to hold 13,147, and reduced Zoetis by 95.6%, selling 251,749 shares to hold 11,600.
- **2026-03-31**: Q1 2026 Nebius position increases — Amundi lifted Nebius by 10.6% to 1,343,954 shares worth $139,449,000; Lombard Odier, HB Wealth Management, Wealth Alliance, Empirical Financial Services, and Aspen Grove Capital also added or initiated Nebius positions.
- **2025-12-31**: Q4 2025 institutional accumulation — Geode Capital Management boosted its Nebius stake by 1,095.7% to 2,046,799 shares worth $169,840,000, while Vanguard added 12.9% to its Zoetis position and J. Stern & Co. lifted Zoetis by 12,431.2%.

## Recent coverage (9 stories, network-wide)

### Wyoming Buys 3,879 CAH Shares; $54.6B Cardinal Health Draws Vanguard, Norges
2026-08-17 03:18:16 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The State of Wyoming disclosed new Q2 2026 13F positions in Cardinal Health ($921K) and Builders FirstSource ($828K), but the larger signal is institutional accumulation: CAH is 87.17% institutionally owned with Vanguard and Norges adding, while BLDR is 95.53% owned despite a Q2 earnings miss.
Full story: https://getfinancebrief.com/story/wyoming-cah-bldr-13f-institutional-ownership

### Cbus Trustee Cuts Nebius 20.5% and Zoetis 95.6% in Q2 13F
2026-08-17 01:10:14 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

United Super, in its capacity as trustee for the Construction & Building Unions Superannuation Fund, cut its Nebius stake by 20.5% to $3.63 million and nearly exited Zoetis, reducing that position by 95.6% to $834,000 in Q2 2026. The 13F reveals rotation away from animal health while retaining AI-infrastructure exposure.
Full story: https://getfinancebrief.com/story/cbus-trustee-cuts-nebius-zoetis-q2-13f

### Safe Pro Group Misses EPS by $0.01, Yet Jumps 37.7% to $6.17
2026-08-15 00:36:38 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Safe Pro Group reported a quarterly EPS of -$0.15, one cent below consensus, but shares soared 37.7% on 21x average volume. The move pushed market cap to $128.89M even as negative net margin widened to 800.91%.
Full story: https://getfinancebrief.com/story/safe-pro-group-earnings-miss-eps-stock-surge

### ENSC Shorts Up 619.9% at $0.30; FCUV Revenue $0.05M
2026-08-13 01:23:24 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Ensysce Biosciences short interest soared 619.9% to 364,278 shares as its stock trades at $0.30, while Focus Universal posted just $0.05M in quarterly revenue. The data highlights severe financial fragility across two small healthcare and device innovators.
Full story: https://gethealthbrief.com/story/ensc-shorts-up-619-9-fcuv-revenue-0-05m

### SCYX Short Interest Plunges 87.6% as ENSC Spikes 619.9%
2026-08-13 01:23:11 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

SCYNEXIS shorts collapsed 87.6% to 320,181 shares, signaling bear exhaustion, while Ensysce Biosciences short interest exploded 619.9% to 364,278. Focus Universal also saw a 282.8% build, reflecting a stark divergence in microcap biotech sentiment.
Full story: https://getbiobrief.com/story/scyx-short-interest-plunges-87-6-ensc-spikes-619-9

### Shuttle Pharma Insider Spends $110K on 32.5K Shares at 94% Discount from High
2026-07-05 23:48:59 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 4

A major Shuttle Pharmaceuticals shareholder just poured $110,694 into the beaten-down stock, buying 32,591 shares at near all-time lows. For healthcare investors, this insider vote of confidence in a radiation oncology developer could signal upcoming clinical catalysts or a potential turnaround.
Full story: https://gethealthbrief.com/story/shuttle-pharma-insider-buying-signal-healthcare

### Insider Bet of $110K on Shuttle Pharma Amid 94% Crash—Pipeline Catalyst Ahead?
2026-07-05 23:48:51 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 4

A $110,694 insider purchase by Financial Lp Hrt in Shuttle Pharmaceuticals boosts the owner’s stake to 78,597 shares just as the micro-cap trades near $2.90 lows. For biotech investors, this accumulation could reflect confidential knowledge about the radiation sensitizer pipeline's progress.
Full story: https://getbiobrief.com/story/shuttle-pharma-insider-buy-biotech-pipeline

### Paragon Capital’s 288.8% NVIDIA Boost Mirrors $62.2B Institutional Wave
2026-06-28 03:23:06 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A wave of institutional buying in NVIDIA highlights the stock’s allure, with Paragon Capital’s Q1 2026 filing revealing a 288.8% stake increase. The move underscores how deep the conviction runs among hedge funds and sovereign wealth funds.
Full story: https://getfinancebrief.com/story/finance-nvidia-institutional-paragon-288

### Evolv Tech Sees $1.43M Institutional Bet; 66.65% of Float Now Held by Funds
2026-06-23 00:12:40 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Creek Drive Management Group initiates a $1.4 million position in EVLV, as institutional ownership reaches 66.65%. Large funds like Vanguard and State Street add to positions, and an analyst target of $10 highlights upside potential for the AI security firm.
Full story: https://getfinancebrief.com/story/evlv-institutional-buying-creek-drive-1-43m

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.